These findings clearly show that targeting NHE1 protein by post-stroke HOE642 or Rimeporide administration provides a novel strategy to modulate microglial function for stimulating white matter repair and post-stroke functional recovery. The gene discussed is SLC9A1; the disease is Stroke.